Page 3 - Navin Jacob News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Royalty Pharma announced a 13% hike in its quarterly dividend to $0.17 per share from $0.15.Royalty Pharma (RPRX) said that the new quarterly dividend would be paid by Mar. 15 to shareholders of record as of Feb. 19. Its annual dividend of $0.68 per share now reflects a dividend yield of 1.3%.Earlier on Dec. 7, Royalty Pharma announced that it will acquire a royalty interest in Orladeyo therapy and BCX9930 from BioCryst Pharmaceuticals. Royalty Pharma, along with Athyrium Capital Management, will provide about $325 million in funding for BioCryst to support the launch of Orladey...

By midday Thursday, Moderna stock (ticker; MRNA) was up 4%, to $142, as scientists from Moderna began presenting their analyses of the clinical trials run by the company and federal researchers. The 30,000-person pivotal trial showed the vaccine prevented Covid cases with 94.1% efficacy. That was practically the same as the 95% showing for the Pfizer (PFE) vaccine, and significantly better than interim readouts on other vaccines like that of The Covid pandemic is worsening around the world, noted the FDA’s deputy director for reviewing vaccine trials, Doran Fink, as the day began. Through...